Seniors Advocate Drug Price Negotiation
A study conducted recently by The Senior Citizens League (TSCL) indicates that seniors have an overwhelming preference for Medicare’s negotiations
Read More
Part D/Prescription Drugs
Seniors encouraged to pay more attention to cost in selecting Part D plans
A study by researchers at Yale School of Management concludes that Medicare beneficiaries, when shopping for coverage, often do not end
Read MorePutting a Stop to Doctor-shopping for Painkillers
A new study has found state programs that require physicians to check drug registries before writing prescriptions for opioid pain
Read MoreFlu vaccine is only moderately protective this year, CDC says
(By Helen Branswell for STAT) This year’s flu vaccine is offering moderate protection against the main family of viruses causing
Read More5 Reasons Why An $89,000 Drug Has Congress Fuming
(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) The latest flashpoint in the ongoing debate over high
Read MoreDrugmaker Marathon ‘Pausing’ Delivery Of $89,000-a-year Muscular Dystrophy Drug
(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) In a surprise move Monday, Marathon Pharmaceuticals told patient
Read MoreMedicare Rules: Three that are Important to Know
There are more than 57 million Americans enrolled in Medicare, with more added to the program each month. Here are
Read MoreGrassley Launches Inquiry Into Orphan Drugs After KHN Investigation
(By Sarah Jane Tribble for Kaiser Health News) Republican Sen. Chuck Grassley, chairman of the Senate Judiciary Committee, has opened
Read MoreHow A Simple Fix For Medicare Prescribing Problems Got Complicated
(By Charles Ornstein for NPR) Back in 2014, federal officials settled on what they thought would be a straightforward fix
Read MoreAlzheimer’s-preventing drugs may already exist — we just can’t test them
(By Julie Zissimopoulos for STAT) The search for drugs to prevent or delay Alzheimer’s disease has been a decades-long exercise
Read More